News & Events
News & Events
December 12, 2018
U.S. Food and Drug Administration Awards Contract to Critical Path Institute for Kidney Transplant DatabasePatient-level data will inform the creation of drug development tools and speed development of new immunosuppressive treatments TUCSON, Ariz., December 12, 2018 — The U.S. Food and Drug Administration (FDA) has awarded a contract to Critical Path Institute (C-Path) in support of a new project to create a database of patient-level clinical trial data that...
August 10, 2018
Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized TreatmentThe following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public workshop titled “Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment. This public workshop is planned and presented in collaboration with the Transplant Therapeutics Consortium (TTC), a public-private partnership between the FDA, transplantation...
April 26, 2017
Critical Path Institute Launches Transplant Therapeutics ConsortiumApril 26, 2017 Critical Path Institute Launches Transplant Therapeutics Consortium Tucson, Ariz., April 26, 2017 –Critical Path Institute (C-Path) is pleased to announce the launch of the Transplant Therapeutics Consortium (TTC), co-founded by the two leading US organizations in organ transplantation: the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS)....